Left ventricular dysfunction in relation with systemic inflammation in chronic obstructive pulmonary disease patients

Sule Tas Gulen1, Ufuk Eryilmaz2, Mustafa Yilmaz3

  • 1Department of Chest Diseases, Adnan Menderes University School of Medicine, Aydin, Turkey.

Insights

Cardiovascular disease (CVD) impacts left ventricular function in chronic obstructive pulmonary disease (COPD) patients, even before clinical symptoms appear. Echocardiographic findings correlate with COPD functional status, highlighting the link between respiratory and cardiac health.

Area of Science:

  • Cardiology
  • Pulmonology
  • Biomarkers

Background:

  • Cardiovascular disease (CVD) is a leading cause of mortality in patients with chronic obstructive pulmonary disease (COPD).
  • Understanding the subclinical cardiac impact of COPD is crucial for improving patient outcomes.

Purpose of the Study:

  • To assess echocardiographic parameters in COPD patients with and without pre-existing CVD.
  • To investigate the relationship between echocardiographic findings and systemic inflammation markers in COPD.

Main Methods:

  • Echocardiography was used to measure left and right ventricular systolic and diastolic function in 60 stable COPD patients (23 with CVD, 37 without) and 21 controls.
  • Systemic inflammation markers (HsCRP, IL-8, fetuin-A, CCL-16, NT-proBNP) and functional tests (6MWT, CAT, BODE index) were evaluated.

Main Results:

  • COPD patients exhibited elevated systemic inflammation and lower fetuin-A levels.
  • Patients with COPD and CVD showed reduced left ventricular ejection fraction (LVEF) and increased left ventricular dimensions (LVED, LVES) compared to those without CVD.
  • Aortic diameter was larger in COPD patients, and fetuin-A correlated with aortic and LVES diameters. LVEF, LVED, and LVES correlated with COPD functional parameters.

Conclusions:

  • Left ventricular function is impaired in COPD patients, often preceding overt cardiac symptoms.
  • Echocardiographic parameters are significantly correlated with the functional status of COPD patients, underscoring the cardiorespiratory link.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.5K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.7K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.2K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
5.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.7K